Pathstone Family Office, LLC Chroma Dex Corp. Transaction History

Pathstone Family Office, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 10, 2018	SELL	$3.22 - $4.43 $9,660 - $13,290	-3,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.05 - $6.46 $12,150 - $19,380	3,000 New	3,000 $13,000
Q4 2017 Feb 12, 2018	SELL	$3.88 - $6.96 $11,640 - $20,880	-3,000 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	3,000	3,000 $11,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $466M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.